|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.14 CHF | +1.08% |
|
+4.32% | +14.18% |
| 14/02 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| 14/02 | Sector Update: Health Care Stocks Higher Friday Afternoon | MT |
| Capitalization | 311B 262B 239B 228B 423B 28,141B 440B 2,777B 1,103B 13,590B 1,165B 1,141B 47,497B | P/E ratio 2026 * |
21.5x | P/E ratio 2027 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise value | 344B 289B 264B 252B 468B 31,113B 486B 3,071B 1,219B 15,025B 1,288B 1,262B 52,513B | EV / Sales 2026 * |
6x | EV / Sales 2027 * | 5.63x |
| Free-Float |
87.19% | Yield 2026 * |
2.7% | Yield 2027 * | 2.78% |
Last Transcript: Novartis AG
| 1 day | +1.08% | ||
| 1 week | +4.32% | ||
| Current month | +9.18% | ||
| 1 month | +10.12% | ||
| 3 months | +18.35% | ||
| 6 months | +28.32% | ||
| Current year | +14.18% |
| 1 week | 119.74 |  | 125.42 |
| 1 month | 112.74 | | 125.42 |
| Current year | 107.68 | | 125.42 |
| 1 year | 81.1 | | 125.42 |
| 3 years | 73.74 | | 125.42 |
| 5 years | 72.84 | | 125.42 |
| 10 years | 65.09 | | 125.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
| Director of Finance/CFO | 61 | 24/04/2013 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 10.4% | 121 M€ | |
| -0.48% | 5.57% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.08% | +4.32% | +27.98% | +55.61% | 311B | |
| +0.33% | -1.72% | +23.18% | +199.23% | 929B | |
| -0.45% | +1.44% | +55.91% | +50.24% | 587B | |
| +1.76% | +3.61% | +20.03% | +51.71% | 409B | |
| +0.08% | +1.01% | +20.89% | +28.94% | 374B | |
| +1.42% | +7.19% | +26.36% | +32.36% | 320B | |
| +1.82% | -0.43% | +46.26% | +11.65% | 301B | |
| +1.32% | +5.11% | -45.12% | -37.51% | 219B | |
| +1.52% | -3.94% | +26.80% | +53.17% | 199B | |
| +2.09% | +1.63% | +48.90% | +80.88% | 192B | |
| Average | +1.10% | +1.96% | +25.12% | +52.63% | 384.1B | |
| Weighted average by Cap. | +0.81% | +1.58% | +27.66% | +76.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.26B 48.25B 44.01B 42.01B 77.99B 5,186B 81.03B 512B 203B 2,504B 215B 210B 8,753B | 59.74B 50.33B 45.91B 43.83B 81.36B 5,411B 84.53B 534B 212B 2,613B 224B 219B 9,132B |
| Net income | 14.51B 12.22B 11.15B 10.64B 19.76B 1,314B 20.53B 130B 51.47B 634B 54.4B 53.28B 2,217B | 15.9B 13.4B 12.22B 11.66B 21.65B 1,440B 22.5B 142B 56.41B 695B 59.62B 58.39B 2,430B |
| Net Debt | 32.81B 27.64B 25.21B 24.07B 44.68B 2,972B 46.43B 293B 116B 1,435B 123B 121B 5,015B | 25.36B 21.37B 19.49B 18.61B 34.55B 2,297B 35.89B 227B 90.01B 1,109B 95.12B 93.17B 3,877B |
Employees
75,267
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 125.14 CHF | +1.08% | 4,755,788 |
| 12/02/26 | 123.80 CHF | +0.57% | 3,348,098 |
| 11/02/26 | 123.10 CHF | +1.74% | 4,177,152 |
| 10/02/26 | 121.00 CHF | +0.67% | 3,106,255 |
| 09/02/26 | 120.20 CHF | +0.20% | 3,339,717 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
162.83USD
Average target price
148.67USD
Spread / Average Target
-8.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition